It included the patients in whom during urination certain changes in HM were registered. The Group 1 patients' age varied from 63 to 79 years (mean 68.6±4.94 years). Nearly all except two patients (cardiac background of these patients did not require medical or surgical correction) from this group received cardiotropic therapy which did not change during one-month follow-up.

This group enrolled 28 patients in whom primary HM detected certain alterations (VE, SVE, ST segment depression) which did not coincide with the act of urination. The age of patients was from 57 to 81 years (mean 71.3±1.1 years). In order to improve impaired urination were also received Tamsulosin at a dose of 0.4 mg once daily (in the morning) for the whole period of follow up and treatment. Tamsulosin Oral Capsule.

This group was composed of patients for whom after examination for symptoms of IHD and LUTS/BPH a decision was made on the necessity to perform operative treatment of BPH. TURP operation was indicated due to pronounced urination disorders which were most important amongst the patient's complaints. The patients' age varied from 59 to 77 years (mean 67.5±2.1 years).

Ischaemic Heart Disease (IHD)

Benign Prostatic Hyperplasia (BPH)

Lower Urinary Tract Symptoms (LUTS)

Benign prostatic hyperplasia - is a disease diagnosed only in males older than 50 years

Tamsulosin Oral Capsule - alpha-1-adrenoblocker for treatment LUTS/BPH 0.4 mg

Tamsulosin Oral Capsule

Routine transurethral prostatic resection

TURP

Benign Prostatic Hyperplasia and Ischemic Heart DIsease

Changes of the ST segment and of the cardiac rhythm during urination, which was registered by the patient by depressing the respective button on the device and keeping a diary, and totally during the whole period (24 hours) of Holter monitoring.

urinary retention/triglyceride

Benign Prostatic Hyperplasia and Ischemic Heart DIsease

Den mest komplette database med medicinske urter understøttet af videnskab